Loader

Pathways

PathWhiz ID Pathway Meta Data

PW002529

Pw002529 View Pathway
metabolic

Aspartate Metabolism

Arabidopsis thaliana
Aspartate is synthesized from oxaloacetic acid and l-glutamate in the cytosol, the chloroplast, the mitochondria and the peroxisome. Aspartate is broken down via conversion to malate, a part of the reversible malate-aspartate shuttle in the mitochondrial and cytoplasmic space. This shuttle involves the transfer of reduction equivalents across the mitochondrial membrane to produce ATP. NADH is unable to cross the inner mitochondrial membrane. Therefore, the shuttle allows electrons from NADH in the cytosol, a product of glycolysis, to cross the inner mitochondrial membrane to produce ATP.

PW064572

Pw064572 View Pathway
metabolic

Aspartate Metabolism

Mus musculus
Aspartate is synthesized by transamination of oxaloacetate by aspartate aminotransferase or amino acid oxidase. Aspartyl-tRNA synthetase can then couple aspartate to aspartyl tRNA for protein synthesis. The aspartate content in human proteins is about 7%. Asparagine synthase can convert aspartate to the polar amino acid asparagine. Aspartate is also a precursor for cellular signaling compounds such as, N-acetyl-aspartate, beta-alanine, adenylsuccinate, arginino-succinate and N-carbamoylaspartate. Aspartate is also a metabolite in the urea cycle and involved in gluconeogenesis. Additionally, aspartate carries the reducing equivalents in the mitochondrial malate-aspartate shuttle, which utilizes the ready interconversion of aspartate and oxaloacetate. The conjugate base of L-aspartic acid, aspartate, also acts as an excitatory neurotransmitter in the brain which activates NMDA receptors.

PW088445

Pw088445 View Pathway
metabolic

Aspartate Metabolism

Caenorhabditis elegans
Aspartate is synthesized by transamination of oxaloacetate by aspartate aminotransferase or amino acid oxidase. Aspartyl-tRNA synthetase can then couple aspartate to aspartyl tRNA for protein synthesis. The aspartate content in human proteins is about 7%. Asparagine synthase can convert aspartate to the polar amino acid asparagine. Aspartate is also a precursor for cellular signaling compounds such as, N-acetyl-aspartate, beta-alanine, adenylsuccinate, arginino-succinate and N-carbamoylaspartate. Aspartate is also a metabolite in the urea cycle and involved in gluconeogenesis. Additionally, aspartate carries the reducing equivalents in the mitochondrial malate-aspartate shuttle, which utilizes the ready interconversion of aspartate and oxaloacetate. The conjugate base of L-aspartic acid, aspartate, also acts as an excitatory neurotransmitter in the brain which activates NMDA receptors.

PW002375

Pw002375 View Pathway
metabolic

Aspartate Metabolism

Saccharomyces cerevisiae
Aspartate (also named as L-aspartic acid) is an α-amino acid that can be used for protein biosynthesis. Oxalacetic acid is produced from aspartic acid by mitochondrial aspartate aminotransferase, then oxalacetic acid is reduced to malic acid by malate dehydrogenase. Malic acid enters mitochondria through mitochondrial dicarboxylate transporter and forms oxalacetic acid by facilitation of malate dehydrogenase. In the final step, oxalacetic acid is catalyzed by mitochondrial aspartate aminotransferase to form aspartate.

PW064431

Pw064431 View Pathway
metabolic

Aspartate Metabolism 1512214152

Homo sapiens

PW126786

Pw126786 View Pathway
metabolic

Aspartate Metabolism 1648490207

Pseudomonas aeruginosa
Aspartate is synthesized from and broken down to oxaloacetate, a TCA cycle intermediate, via a reversible transamination reaction with glutamate. This reaction is catalyzed by the aminotransferase AspC or TyrB. Aspartate is a component of proteins and is involved in many biosyntheses pathways like NAD biosynthesis and beta-alanine metabolism. Aspartate can also be synthesized from fumaric acid through an aspartate ammonia lyase. Aspartate also participates in the synthesis of L-asparagine through two different methods, either through aspartate ammonia ligase or asparagine synthetase B. Aspartate is also a precursor of fumaric acid. Again it has two possible ways of synthesizing it. First set of reactions follows an adenylo succinate synthetase that yields adenylsuccinic acid and then adenylosuccinate lyase in turns leads to fumaric acid. The second way is through argininosuccinate synthase that yields argininosuccinic acid and then argininosuccinate lyase in turns leads to fumaric acid.

PW126787

Pw126787 View Pathway
metabolic

Aspartate Metabolism 1648490310

Pseudomonas aeruginosa
Aspartate is synthesized from and broken down to oxaloacetate, a TCA cycle intermediate, via a reversible transamination reaction with glutamate. This reaction is catalyzed by the aminotransferase AspC or TyrB. Aspartate is a component of proteins and is involved in many biosyntheses pathways like NAD biosynthesis and beta-alanine metabolism. Aspartate can also be synthesized from fumaric acid through an aspartate ammonia lyase. Aspartate also participates in the synthesis of L-asparagine through two different methods, either through aspartate ammonia ligase or asparagine synthetase B. Aspartate is also a precursor of fumaric acid. Again it has two possible ways of synthesizing it. First set of reactions follows an adenylo succinate synthetase that yields adenylsuccinic acid and then adenylosuccinate lyase in turns leads to fumaric acid. The second way is through argininosuccinate synthase that yields argininosuccinic acid and then argininosuccinate lyase in turns leads to fumaric acid.

PW144271

Pw144271 View Pathway
drug action

Aspartic acid Drug Metabolism Action Pathway

Homo sapiens

PW000458

Pw000458 View Pathway
disease

Aspartylglucosaminuria

Homo sapiens
Aspartylglucosaminuria is an autosomal recessive disorder of lysosomal storage caused by a mutation in the AGA gene which codes for N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase. A deficiency in this enzyme results in accumulation of aspartylglycosamine and oligosaccharides in urine. Symptoms, which present in childhood, include skeletal changes, speech abnormalities, macroglossia, and mental retardation. Treatment includes bone marrow transplants.

PW147009

Pw147009 View Pathway
metabolic

Aspirin Drug Metabolism Pathway

Homo sapiens